$15.420
+0.527 (+3.42%)收盘时
CARL 资讯
CARL 事件
Carlsmed Launches aprevo Lumbar Bi-lateral Posterior System in U.S.
Carlsmed announced the U.S. commercial launch of its aprevo Lumbar Bi-lateral Posterior System at the North American Spine Society's 41st Annual Meeting, or NASS, in San Antonio, Texas. The launch follows a limited market evaluation that commenced in February 2026, with the first in human procedure completed on February 10.
Carlsmed Appoints Tony Jarc as Chief Product and AI Officer
Carlsmed announced that Tony Jarc, Ph.D. has been appointed to the newly-created position of Chief Product and AI Officer, effective immediately. Dr. Jarc will lead the development and commercialization of the Company's next generation technology platform, surgical UI/UX, and personalized spine surgery procedures.
Carlsmed Appoints Richard Heppenstall as CFO
Carlsmed announced that Richard Heppenstall has been appointed Chief Financial Officer, effective immediately. Heppenstall succeeds Leo Greenstein, who has served as CFO since 2023 and will be leaving Carlsmed to pursue other professional interests. Heppenstall previously served as the Executive Vice President, Chief Financial Officer and Treasurer of ZimVie
Carlsmed Files Patent Infringement Lawsuit Against DeGen Medical in South Carolina
Carlsmed filed a patent infringement lawsuit against DeGen Medical in the United States District Court for the District of South Carolina Florence Division. The complaint asserts that DeGen is infringing eight of Carlsmed's patents relating to its implants, methods and systems. Carlsmed is seeking injunctive relief and damages for infringement. "Carlsmed is dedicated to advancing the standard of care in spine surgery through our proprietary personalized spine surgery solutions and bringing value to patients, surgeons, and payors every day. We are committed to protecting the intellectual property that supports our patient-centric innovation, which remains at the forefront of the industry," said Mike Cordonnier, Chairman and CEO of Carlsmed.
Carlsmed Appoints Jeff Bertolini as COO
Carlsmed announced that Jeff Bertolini has been promoted to the role of COO, effective immediately. Jeff joined Carlsmed in September 2024, most recently serving as the company's senior VP, operational excellence and previously, VP of advanced manufacturing technologies.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。